SERUM ESTRIOL LEVELS DURING BETA -RECEPTOR AGONIST INFUSION IN THE THIRD TRIMESTER OF PREGNANCYBREMME K; ENEROTH P.1981; GYNECOL. OBSTETR. INVEST.; CHE; DA. 1981; VOL. 12; NO 2; PP. 93-98; BIBL. 10 REF.Article

CHANGES IN SERUM HORMONE LEVELS DURING LABOR INDUCED BY ORAL PGE₂ OR OXYTOXIN INFUSIONBREMME K; ENEROTH P.1980; ACTA OBSTET. GYNECOL. SCAND., SUPPL.; ISSN 0300-8835; SWE; DA. 1980; NO 92; PP. 31-43; BIBL. 56 REF.Article

A COMPARATIVE STUDY OF UTERINE ACTIVITY AND FETAL HEART RATE PATTERN IN LABOR INDUCED WITH ORAL PROSTAGLANDIN E₂ OR OXYTOCINBREMME K; BYGDEMAN M.1980; ACTA OBSTET. GYNECOL. SCAND., SUPPL.; ISSN 0300-8835; SWE; DA. 1980; NO 92; PP. 23-29; BIBL. 62 REF.Article

PROPHYLACTIC SALPINGO-OOPHORECTOMY IN CANCER OF THE CERVIXBREMME K; EINHORN N.1979; ACTA OBSTETR. GYNECOL. SCAND.; SWE; DA. 1979; VOL. 58; NO 2; PP. 183-186; BIBL. 22 REF.Article

INDUCTION OF LABOR BY OXYTOCIN OR PROSTAGLANDIN E₂BREMME K; BYGDEMAN M.1980; ACTA OBSTET. GYNECOL. SCAND., SUPPL.; ISSN 0300-8835; SWE; DA. 1980; NO 92; PP. 11-21; BIBL. 54 REF.Article

AN OLD PROBLEM REVISITED - HYALINE MEMBRANE DISEASE AND CESAREAN SECTIONFAXELIUS G; BREMME K; LAGERCRANTZ H et al.1982; EUROPEAN JOURNAL OF PEDIATRICS; ISSN 0340-6199; DEU; DA. 1982; VOL. 139; NO 2; PP. 121-124; BIBL. 20 REF.Article

INTERRUPTION OF EARLY TRIMESTER PREGNANCY BY SINGLE VAGINAL ADMINISTRATION OF 15-METHYL-PGF2ALPHA -METHYL ESTERGREEN K; BYGDEMAN M; BREMME K et al.1978; CONTRACEPTION; USA; DA. 1978; VOL. 18; NO 6; PP. 551-560; BIBL. 12 REF.Article

MATERNAL SERUM HORMONE CHANGES DURING ABORTION INDUCED WITH 16,16-DIMETHYL-TRANS-DELTA ²-PGE₁ METHYL ESTERBREMME K; ENEROTH P; BYGDEMAN M et al.1982; PROSTAGLANDINS LEUKOT. MED.; GBR; DA. 1982; VOL. 8; NO 6; PP. 647-651; BIBL. 24 REF.Article

DISTRIBUTION OF TUMOR-ASSOCIATED ANTIGEN CEA AND CROSS-REACTING NCA IN FETAL ORGANSGADLER H; BREMME K; WAHREN B et al.1980; INTERNATION. J. CANCER; CHE; DA. 1980; VOL. 25; NO 1; PP. 91-94; BIBL. 11 REF.Article

AN EVALUATION OF EARLY PREGNANCY HCG DETERMINATION AS A PROGNOSTIC TOOL FOR FETAL OUTCOMEBREMME K; ENEROTH P; NORD E et al.1983; GYNECOLOGIC AND OBSTETRIC INVESTIGATION; ISSN 0378-7346; CHE; DA. 1983; VOL. 16; NO 3; PP. 160-171; BIBL. 45 REF.Article

ON THE USE OF ALPHA -FETOPROTEIN AND PROLACTIN IN PRENATAL DIAGNOSIS OF FETAL ABNORMALITIES IN EARLY PREGNANCIESBREMME K; ENEROTH P; NILSSON B et al.1982; INT. J. GYNAECOL. OBSTET.; ISSN 0020-7292; USA; DA. 1982; VOL. 20; NO 4; PP. 293-300; BIBL. 34 REF.Article

INDUCTION OF LABOR BY ORAL PGE₂ ADMINISTRATION. EVALUATION OF DIFFERENT DOSE SCHEDULESBREMME K; KINDAHL H; SVANBORG K et al.1980; ACTA OBSTET. GYNECOL. SCAND., SUPPL.; ISSN 0300-8835; SWE; DA. 1980; NO 92; PP. 5-10; BIBL. 34 REF.Article

CHANGES IN MATERNAL SERUM ALDOSTERONE, POTASSIUM AND PROLACTIN LEVELS DURING BETA -RECEPTOR AGONIST TREATMENT IN THIRD TRIMESTER PREGNANCIESBREMME K; ENEROTH P; HAGENFELD L et al.1982; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1982; VOL. 14; NO 4; PP. 198-204; BIBL. 3 P.Article

Production of phospholipid antibodies in selected thrombophilic women differing in genotype at the 506 site of factor VBOKAREWA, M. I; BREMME, K.European journal of haematology. 1998, Vol 61, Num 1, pp 21-26, issn 0902-4441Article

CATECHOLAMINE METABOLITES IN AMNIOTIC FLUID AS INDICATORS OF INTRAUTERINE STRESSLAGERCRANTZ H; SJOQUIST B; BREMME K et al.1980; AMER. J. OBSTETR. GYNECOL.; USA; DA. 1980; VOL. 136; NO 8; PP. 1067-1070; BIBL. 12 REF.Article

Monitoring of a woman with protein C deficiency during pregnancy and the effects of heparinBREMME, K; BLOMBÄCK, M.Thrombotic and haemorrhagic disorders. 1992, Vol 5, Num 1, pp 11-15, issn 0934-9669Article

THE REGULATION IN VITRO OF PLACENTAL RELEASE OF HUMAN CHORIONIC GONADOTROPIN, PLACENTAL LACTOGEN, AND PROLACTIN: EFFECTS OF AN ADRENERGIC BETA-RECEPTOR AGONIST AND ANTAGONISTSHU RONG Z; BREMME K; ENEROTH P et al.1982; AM. J. OBSTET. GYNECOL.; ISSN 0002-9378; USA; DA. 1982; VOL. 143; NO 4; PP. 444-450; BIBL. 24 REF.Article

Hemostatic abnormalities may predict chronic hypertension after preeclampsiaBREMME, K; BLOMBÄCK, M.Gynecologic and obstetric investigation. 1996, Vol 41, Num 1, pp 20-26, issn 0378-7346Article

CARCINOEMBRYONIC ANTIGEN IN AMNIOTIC FLUID.GADLER H; WAHREN B; LINDSTEN J et al.1977; ACTA MED. SCAND.; SUEDE; DA. 1977; VOL. 201; NO 5; PP. 411-413; BIBL. 12 REF.Article

Low molecular mass heparin (LMMH) for management of thromboembolic disease in pregnancy. DiscussionVAN ROOIJEN, M; BRYNGELSSON, A. L; BREMME, K et al.Acta obstetricia et gynecologica Scandinavica. 2005, Vol 84, Num 10, pp 1018-1019, issn 0001-6349, 2 p.Article

Elevation of plasma leptin levels during pregnancy in normal and diabetic womenSTOCK, S. M; BREMME, K. A.Metabolism, clinical and experimental. 1998, Vol 47, Num 7, pp 840-843, issn 0026-0495Article

Women with prolactin-producing pituitary adenoma show decreased serum placental lactogen during pregnancyLUTHMAN, M; BREMME, K; ENEROTH, P et al.Gynecologic and obstetric investigation. 1993, Vol 35, Num 2, pp 80-85, issn 0378-7346Article

Hormone levels in amniotic fluid and maternal serum in women who undergo spontaneous abortion after second trimester amniocentesisBREMME, K; ENEROTH, P; NILSSON, B et al.Gynecologic and obstetric investigation. 1984, Vol 18, Num 2, pp 78-82, issn 0378-7346Article

A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary resultsSHU HE; BREMME, K; BLOMBÄCK, M et al.Thrombosis research. 1999, Vol 96, Num 2, pp 145-156, issn 0049-3848Article

Arg⁵⁰⁶-Gln mutation in factor V and risk of thrombosis during pregnancyBOKAREWA, M. I; BREMME, K; BLOMBÄCK, M et al.British journal of haematology. 1996, Vol 92, Num 2, pp 473-478, issn 0007-1048Article